Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept
M Rudwaleit, X Baraliakos, J Listing, J Brandt, J Sieper, and J Braun

There is an error in the legend of figure 2 of this article. The legend should read:

Improvement of inflammatory spinal lesions in a patient with ankylosing spondylitis in the T1/Gd-DTPA MRI sequence before (A) and after (B) treatment with etanercept. The hyperintensity of the signal in the vertebra is no more detectable after 6 weeks of therapy with etanercept.